19095372

Source:http://linkedlifedata.com/resource/pubmed/id/19095372

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0033727, umls-concept:C0037949, umls-concept:C0086805, umls-concept:C0282460, umls-concept:C1261473, umls-concept:C1273870, umls-concept:C1522449
pubmed:issue	3
pubmed:dateCreated	2009-6-1
pubmed:abstractText	Radiotherapy (XRT) for spine sarcomas is constrained by spinal cord, nerve, and viscera tolerance. Negative surgical margins are uncommon; hence, doses of >or=66 Gy are recommended. A Phase II clinical trial evaluated high-dose photon/proton XRT for spine sarcomas.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/P01 CA021239-27, http://linkedlifedata.com/resource/pubmed/grant/P01 CA021239-28, http://linkedlifedata.com/resource/pubmed/grant/P01CA021239
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-11283918, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-11953605, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-12431970, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-12738323, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-14069783, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-15050341, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-15131446, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-15355901, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-15850902, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-15993548, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-16199316, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-16372417, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-17084540, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-17138225, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-17394945, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-1869936, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-2408725, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-2535872, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-3001976, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-6330772, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-6406404, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-6863054, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-7677836, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-7852108, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-8431853, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-890662, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095372-9440743
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Protons
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1879-355X
pubmed:author	pubmed-author:AdamsJudithJ, pubmed-author:DeLaneyThomas FTF, pubmed-author:DeanSusanS, pubmed-author:HarmonDavid CDC, pubmed-author:HornicekFrancis JFJ, pubmed-author:LiebschNorbert JNJ, pubmed-author:McManusPatriciaP, pubmed-author:NielsenG PeturGP, pubmed-author:PedlowFrancis XFX, pubmed-author:RaskinKevin AKA, pubmed-author:RosenbergAndrew EAE, pubmed-author:SpiroIra JIJ, pubmed-author:SuitHerman DHD, pubmed-author:YeapBeow YBY, pubmed-author:YoonSam SSS
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	74
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	732-9
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19095372-Humans, pubmed-meshheading:19095372-Neoplasm, Residual, pubmed-meshheading:19095372-Osteosarcoma, pubmed-meshheading:19095372-Photons, pubmed-meshheading:19095372-Prospective Studies, pubmed-meshheading:19095372-Protons, pubmed-meshheading:19095372-Radiation Tolerance, pubmed-meshheading:19095372-Radiotherapy, Conformal, pubmed-meshheading:19095372-Radiotherapy Dosage, pubmed-meshheading:19095372-Relative Biological Effectiveness, pubmed-meshheading:19095372-Sarcoma, pubmed-meshheading:19095372-Sarcoma, Ewing, pubmed-meshheading:19095372-Spinal Cord, pubmed-meshheading:19095372-Spinal Neoplasms
pubmed:year	2009
pubmed:articleTitle	Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.
pubmed:affiliation	Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. tdelaney@partners.org
pubmed:publicationType	Journal Article, Clinical Trial, Phase II, Research Support, N.I.H., Extramural